Anti-inflammatory compound shows potential in treating patients with severe COVID-19

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from McGovern Medical School and other institutions. A team…


Soto receives $13 million NIH grant

A five-year, $13 million grant to study how certain infectious agents evolve to spread chronic wasting disease (CWD) has been awarded to a UTHealth Houston research team led by Claudio Soto, PhD, from the National Institutes of Health (NIH). Soto, principal investigator…


Multiple Sclerosis Patient Education Day set for April 16

The Division of Multiple Sclerosis and Neuroimmunology in the Department of Neurology will host a Patient Education Day, Saturday April 16 at the Denton A. Cooley, MD & Ralph C. Cooley, DDS University Life Center (7440 Cambridge St.). The event…


Researchers studying how special MRI protocol can help treat patients with brain hemorrhages

A study designed to determine how magnetic resonance imaging (MRI) can be used to help clinicians treat patients with brain hemorrhages is underway at McGovern Medical School at UTHealth Houston. The trial, led by Muhammad Haque, PhD, assistant professor of neurology and…


Tsvetkov wins BIG Award

Andrey Tsvetkov, PhD, assistant professor in the Department of Neurology, has been awarded the Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award from the American Federation for Aging Research (AFAR). The BIG Awards provide $300,000 for research projects…


Research examines impact of social determinants on stroke

A trial testing whether multidisciplinary telehealth intervention will help improve racial disparities in outcomes for adult stroke survivors will be launched at The University of Texas Health Science Center at Houston (UTHealth Houston) with a $3.1 million grant from the…


McCullough and Liu awarded $3.7M NIH grant to study sex differences in COVID-19 outcomes

A $3.7 million grant to identify patients at risk for developing chronic consequences of COVID-19 infection and discover potential underlying mechanisms leading to neuropsychiatric symptoms (NPS) has been awarded to Louise McCullough, MD, PhD, and Fudong Liu, MD, MSN, by…


MEG Center publishes five papers in calendar year

Highlighting the work of the Magnetoencephalography (MEG) Center at McGovern Medical School, Michael Funke, MD, PhD, associate professor in the Department of Pediatrics and director of the MEG Center, and his team have published five papers in various journals over…


Biobank Repository helps chronic coronavirus symptoms

More than a year after COVID-19 sent her to the hospital for seven days, which included treatment with low amounts of supplemental oxygen, Sophia Holton is still suffering symptoms from the virus: headaches, pain, shortness of breath, and low energy….


JAMA Neurology publishes Sarraj research on ischemic stroke

International research from a multicenter study, led by McGovern Medical School neurologists, is providing more guidance on stroke treatment. The study, led by Amrou Sarraj, MD, associate professor in the Department of Neurology and published in JAMA Neurology focuses on patients suffering…


Pages